: iStockAnalyst.com Symbols Feed

Earnings Reports Before Market Open (07/16/2008)

Wed, 16 Jul 2008 07:29:00 GMT

Ticker: MTOX,ABT,AMB,DAL,FMBI,FRGB,GCI,HST,LSTR,LUFK,MI,NTRS,ORCT,PJC,WFC,VLY[More...]

Earnings Report: 04/16/2008

Wed, 16 Apr 2008 22:42:19 GMT

Ticker: SPSN,WFC,ABT,AF,ALTR,AMB,AMR,ATR,CAVM,CCK,CPBK,CRRC,EBAY,ECBE,EDU,GILD,IBM,ITW,JPM,KNL,LEG,NITE,PCBK,PJC,RLI,SYBT,TBI,TCBI,TMK,UFPI,VMI,BLK,CPSS,ISIL,LUFK,MTOX,SLM,STJ,WWW,JCI,LCRY,PLCM[More...]

Companies Reporting Earnings Before Open - 07/17/2007

Mon, 16 Jul 2007 22:47:10 GMT

[More...]

Kinetic Concepts (KCI) "Trading Transparency"

Fri, 13 Jul 2007 15:57:05 GMT

Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisors prior to making any investment decisions based on information on this website.As I mentioned yesterday, my Precision Castparts (PCP) stock hit an appreciation target and I sold 1/7th of my holding. This...[More...]

New Test for Medtox Scientific: As Hiring Has Slowed, Drug Testing Firm Medtox Has Branched Out into Clinical Laboratory Services in the Twin Cities.

Fri, 21 Nov 2008 02:53:00 GMT

Nov. 21--Forget the stock market and the gross domestic product.
The New Brighton-based company is mostly known for providing drug testing services to employers.
"When the economy is strong and people are hiring a lot, our business does very well," said Jim Schoonover, a Medtox vice president and chief marketing officer.

[More...]

MEDTOX Scientific Receives FDA 510(k) Clearance for Additional Three Drugs On the PROFILE(r)-V MEDTOXScan(r) Drugs-of-Abuse Test System

Wed, 29 Jul 2009 12:56:00 GMT

Oxycodone, Propoxyphene and Tricyclic Anitidepressants.[More...]

MEDTOX Scientific Announces Second Quarter Results

Wed, 15 Jul 2009 11:50:00 GMT

ST. PAUL, Minn., July 15, 2009 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced results for the second quarter ended June 30, 2009.
The Company recorded operating income of $0.6 million for the three-month period, compared to $3.1 million for the prior-year period.
Earnings per diluted share were $0.08, compared to $0.39 for the prior-year period.

[More...]

MEDTOX Scientific Announces Second Quarter Conference Call

Tue, 07 Jul 2009 12:57:00 GMT

MEDTOX Scientific, Inc. , announced today that it will hold a teleconference to discuss second quarter results on Wednesday, July 15, at 9:30 a.m. Central Time . During the conference call, the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously. MEDTOX is scheduled to release financial results for the quarter at approximately 6:00 a.m. Central Time on July 15.[More...]

MEDTOX Scientific Announces First Quarter Results; Clinical Lab Revenues Increase of 36%

Wed, 15 Apr 2009 11:46:00 GMT

ST. PAUL, Minn., April 15, 2009 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced results for the first quarter ended March 31, 2009.
MEDTOX achieved a significant increase in new laboratory business for the quarter ended March 31, 2009.
For the three-month period, revenues were $20.7 million, even with the prior-year period.

[More...]

MEDTOX Scientific Announces First Quarter Results

Wed, 15 Apr 2009 10:55:00 GMT

MEDTOX Scientific, Inc. today announced results for the first quarter ended March 31, 2009. MEDTOX achieved a significant increase in new laboratory business for the quarter ended March 31, 2009.[More...]

MEDTOX Scientific Announces First Quarter Conference Call and Annual Meeting Date

Wed, 08 Apr 2009 12:56:00 GMT

MEDTOX Scientific, Inc. , announced today that it will hold a teleconference to discuss first quarter results on Wednesday, April 15, at 9:30 a.m. Central Time . During the conference call, the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously. MEDTOX is scheduled to release financial results for the quarter at approximately 6:00 a.m. Central Time on April 15.[More...]

Photo Release -- MEDTOX Scientific Receives FDA 510(K) Clearance for PROFILE(r)-V MEDTOXScan(r) Drugs-of-Abuse Test System

Thu, 19 Feb 2009 18:17:00 GMT

MEDTOX Scientific, Inc. , announced today that on February 13, 2009, it received 510 clearance from the U.S. Food and Drug Administration to market its PROFILE-V MEDTOXScan Drugs-of-Abuse Test System.[More...]

MEDTOX Scientific Announces Results for Fourth Quarter and Year-End 2008

Wed, 11 Feb 2009 10:56:00 GMT

MEDTOX Scientific, Inc. today announced fourth quarter and year-end results for the periods ended December 31, 2008. MEDTOX achieved record revenues for the quarter and year-ended December 31, 2008.[More...]

MEDTOX Scientific Announces Fourth Quarter and Year-End Conference Call

Wed, 04 Feb 2009 11:55:00 GMT

MEDTOX Scientific, Inc. , announced today that it will hold a teleconference to discuss fourth quarter and year-end results on Wednesday, February 11, at 9:30 a.m. Central Time . During the conference call, the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously. MEDTOX is scheduled to release financial results for the quarter and year-end at approximately 6:00 a.m. Central Time on February 11.[More...]